Victòria Fernández

Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial

Jacqueline Palace, Dean M. Wingerchuk, Kazuo Fujihara et al. · Multiple Sclerosis and Related Disorders · 2020 · 40 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +15

HLA class II and response to interferon-beta in multiple sclerosis

Óscar Fernández, Victòria Fernández, Cristobalina Mayorga et al. · Acta Neurologica Scandinavica · 2005 · 39 citations

Life Sciences, Immunology, Neurology +17

C3, C5a and anti-acetylcholine receptor antibody as severity biomarkers in myasthenia gravis

Florencia Aguirre, Analisa Manín, Victòria Fernández et al. · Therapeutic Advances in Neurological Disorders · 2020 · 36 citations · Full text

Life Sciences, Immunology, Internal Medicine +16

Psychiatric comorbidities and suicidality among patients with neuromyelitis optica spectrum disorders in Argentina

Victòria Fernández, N. Alonso, Luciana Melamud et al. · Multiple Sclerosis and Related Disorders · 2017 · 30 citations

Medicine, Neurology, Psychiatry +4

Clinical and imaging features distinguishing Susac syndrome from primary angiitis of the central nervous system

Mariano Marrodán, Julián Acosta, Lucas Alessandro et al. · Journal of the Neurological Sciences · 2018 · 24 citations

Medicine, Neurology, Neuroradiology +3